MINDCURE Reaches Milestone, Releasing First of its Kind Mental Health Digital Therapeutics Platform to Partner Clinics… Aug 26, 2021
Study Finds Psilocybin ‘Repairs’ Neural Connections In Brain: Psychedelic Stock Developments Aug 25, 2021
Ayr Wellness Announces 5% Share Buyback, the Maximum Allowed for CSE Listed Companies; Reaffirms 2022 Outlook Aug 25, 2021
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative… Aug 25, 2021
MindMed Announces Collaboration With Forian To Advance Development Of Personalized Psychiatry For Anxiety Disorders Aug 24, 2021
Mindset Pharma Broadens its IP Portfolio by Filing U.S. Provisional Patent Extending its DMT and 5-MeO-DMT Inspired… Aug 24, 2021
Gage Growth Corp. Announces Record Second Quarter 2021 Results and Provides Business Update Aug 24, 2021
